Subjects (N = 72) | ||
---|---|---|
Age (years) | 53.8 ± 14.2 | |
Men | 24 (33%) | |
Hypertension | 26 (36%) | |
Diabetes | 11 (15%) | |
CAD | 4 (6%) | |
Smoker | 8 (11%) | |
Cancer Type | Breast | 28 (39%) |
Lymphoma | 35 (49%) | |
Sarcoma | 9 (12%) | |
Chemotherapy type | Anthracycline | 49 (68%) |
Antimicrotubule agents | 48 (67%) | |
Alkylating agents | 56 (78%) | |
Tyrasine-Kinase inhibitors | 28 (39%) | |
Antimetabolites | 4 (6%) | |
Receipt of cardio-protective medications | 24 (33%) |